Antigen-processing polymorphisms in chronic hepatitis C infection

Experimental and Clinical Immunogenetics

Volumn 13, Issue 1, 1996, Pages 7-11

  Höhler, Thomas ^a   Gerken, Guido ^a   Schneider, Peter M ^a   Meyer Zum Büschenfelde, Karl H ^a   Rittner, Christian ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Antigen processing; Hepatitis C; Low molecular weight protein; Transporter associated with antigen processing

Indexed keywords

CARRIER PROTEIN; HLA ANTIGEN CLASS 1; HLA DQ ANTIGEN; PROTEASOME; VIRUS ANTIGEN;

ALLELE; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; ENDOPLASMIC RETICULUM; GENE LOCUS; GENETIC POLYMORPHISM; HEPATITIS C; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN TRANSPORT; SINGLE STRAND CONFORMATION POLYMORPHISM;

ALLELES; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; CHRONIC DISEASE; CYSTEINE ENDOPEPTIDASES; HEPATITIS C; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHISM, GENETIC; PROTEINS;

HEPATITIS C VIRUS;

EID: 0030055064     PISSN: 02549670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Gonzalez-Peralta RP, Davis GL, Lau JYN: Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection. J Hepatol 1994;21:255-259.
2. Meyer zum Büschenfelde K-H, Lohse AW, Gerken G, Treichel U, Löhr HF, Mohr H, Grosse A, Dienes HP: The role of autoimmunity in hepatitis C infection. J Hepatol 1995;22:(suppl 1):93-96.
3. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D, Pape GR: Possible mechanisms involving T-lymphocyte response to nonstructural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995;346:1006-1007.
4. Leroux-Roels G, Esquivel CA, De Leys R, Stuyver L, Elewaut A, Philippe J, Desombere I, Paradijs J, Maertens G: Lymphoproliferative responses to hepatitis virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa. Hepatology 1996;23:8-16.
5. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD: Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992;149:3339-3344.
6. Ballardini G, Groff P, Pontisso P, Giostra F, Francesconi R, Lenzi M, Zauli D, Alberti A, Bianchi FB: Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A, B, C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C. J Clin Invest 1995;95:2067-2075.
7. Bijlmakers MJ, Ploegh HL: Putting together an MHC class I molecule. Curr Opin Immunol 1993;5:21-26.
8. Cerundulo V, Kelly A, Elliot T, Trowsdale J, Townsend A: Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport. Eur J Immunol 1995;25:554-562.
9. Colonna M, Bresnahan M, Bahrain S, Strominger JL, Spies T: Allelic variants of the human putative peptide transporter involved in antigen processing. Proc Natl Acad Sci USA 1992;89:3932-3936.
10. Powis SH, Tonks S, Mockridge I, Kelly AP, Bodmer JG, Trowsdale J: Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2 Immunogenetics 1993; 37:373-380.
11. Maksymowych WP, Wessler A, Schmitt-Egenolf M, Suarez-Almazor M, Titzel G, Von Borstel RC, Pazderka F, Russell AS: Polymorphism in an HLA linked proteasome gene influences phenotypic expression of disease in HLA-B27 positive individuals. J Rheumatol 1994;21:665-669.
12. Hayashi K: PCR-SSCP: a simple and sensitive method for detection of mutations in genomic DNA. PCR Methods Appl 1991;1:34-38.
13. Spinardi L, Mazars R, Theillet C: Protocols for an improved detection of point mutations by SSCP. Nucleic Acids Res 1991;19:4009.
14. Sammons DW, Adams LD, Nishizawe EE: Ultrasensitive silver-based color staining of polypeptides in polyacrylamide gels. Electrophoresis 1981;2:135-141.
15. Campbell DR, Trowsdale J: Map of the human histocompatibility complex. Immunol Today 1993;14:349-352.
16. Howard J: Restrictions on the use of antigenic peptides. Proc Natl Acad Sci USA 1993;90:3777-3779.
17. Hill A, Ploegh H: Getting the inside out: The transporter associated with antigen processing (TAP) and the presentation of viral antigens. Proc Natl Acad Sci USA 1995;92:341-343.
18. Obst R, Armandola EA, Nijenhuis M, Momburg F, Hämmerling GJ: TAP polymorphism does not influence transport of peptide variants in mice and humans. Eur J Immunol 1995;25:2170-2176.